From Philly and the Pa. suburbs to South Jersey and Delaware, what would you like WHYY News to cover? Let us know! Cancer survivors, doctors and advocates in Pennsylvania say proposed cuts to federal ...

With the latest funding round, Blood Cancer United's cumulative research funding tops $2 billion, continuing to help increase survival rates and improve patients' lives Blood Cancer United's new ...

In 2024 alone, more than 2,200 Northeast Ohio residents enrolled in clinical trials through Case Comprehensive Cancer Center (Case CCC), providing access to the latest advances in cancer research.

Heart disease and cancer were again the leading causes of death in the U.S. in 2024, according to a CDC report published Sept. 10, which analyzed 99.9% of 2024 death records as of June 1, 2025. At the ...

Pancreatic cancer survival has finally doubled in a decade to 13 percent, a fragile but real sign that years of slow, methodical progress are beginning to add up. November is Pancreatic Cancer ...

The state of prostate cancer in the U.S. is not exactly great. Just take a look at the “Prostate cancer statistics, 2025” report from the American Cancer Society, published at the beginning of ...

Seattle — July 31, 2025 — Fred Hutch Cancer Center’s summer fundraising event, Obliteride, rolls though Seattle on August 9, rallying thousands to ride, run and walk in support of breakthrough cancer ...

In the high-stakes arena of cancer drug development, SU212 was engineered as a safer twist on podophyllotoxin—a toxic killer designed to halt rogue cell division. Yet in a twist worthy of scientific ...

Chronic inflammation is both a driver and suppressor of cancer depending on context. Key players-NF-κB, IL-6, STAT3, TAMs, MDSCs, and Tregs-orchestrate a tumor-permissive microenvironment.